164 related articles for article (PubMed ID: 19649916)
1. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches.
Sinko PJ
Curr Opin Drug Discov Devel; 1999 Jan; 2(1):42-8. PubMed ID: 19649916
[TBL] [Abstract][Full Text] [Related]
2. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens.
Caldwell GW
Curr Opin Drug Discov Devel; 2000 Jan; 3(1):30-41. PubMed ID: 19649835
[TBL] [Abstract][Full Text] [Related]
3. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
4. Which in vitro screens guide the prediction of oral absorption and volume of distribution?
van de Waterbeemd H
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):162-6. PubMed ID: 15733210
[TBL] [Abstract][Full Text] [Related]
5. When poor solubility becomes an issue: from early stage to proof of concept.
Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening for lead optimization: a rational approach.
Bajpai M; Adkison KK
Curr Opin Drug Discov Devel; 2000 Jan; 3(1):63-71. PubMed ID: 19649839
[TBL] [Abstract][Full Text] [Related]
7. Predicting drug-drug interactions in drug discovery: where are we now and where are we going?
Hutzler M; Messing DM; Wienkers LC
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):51-8. PubMed ID: 15679172
[TBL] [Abstract][Full Text] [Related]
8. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
[TBL] [Abstract][Full Text] [Related]
9. Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development.
Petitet F; Barberan O; Dubus E; Ijjaali I; Donlan M; Ollivier S; Michel A
Expert Opin Drug Discov; 2006 Dec; 1(7):737-51. PubMed ID: 23495997
[TBL] [Abstract][Full Text] [Related]
10. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in computer-aided drug discovery.
Tropsha A
Curr Opin Drug Discov Devel; 2000 May; 3(3):310-3. PubMed ID: 19649864
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening applied to drug synthesis process development.
Cannarsa MJ; Uno T; Larsen C
Curr Opin Drug Discov Devel; 2000 Nov; 3(6):743-9. PubMed ID: 19649902
[TBL] [Abstract][Full Text] [Related]
13. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
14. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
Zolnik BS; Sadrieh N
Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
Baillie TA
Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
[TBL] [Abstract][Full Text] [Related]
16. Making better drugs: Decision gates in non-clinical drug development.
Pritchard JF; Jurima-Romet M; Reimer ML; Mortimer E; Rolfe B; Cayen MN
Nat Rev Drug Discov; 2003 Jul; 2(7):542-53. PubMed ID: 12815380
[TBL] [Abstract][Full Text] [Related]
17. Progress in predicting human ADME parameters in silico.
Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
[TBL] [Abstract][Full Text] [Related]
18. How to achieve confidence in drug discovery and development: managing risk (from a reductionist to a holistic approach).
Bakker A; Caricasole A; Gaviraghi G; Pollio G; Robertson G; Terstappen GC; Salerno M; Tunici P
ChemMedChem; 2009 Jun; 4(6):923-33. PubMed ID: 19434656
[TBL] [Abstract][Full Text] [Related]
19. Solid form screening--a review.
Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
[TBL] [Abstract][Full Text] [Related]
20. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
Beaumont K; Smith DA
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
